A standalone perfusion platform for drug testing and target validation in micro-vessel networks

Biomicrofluidics

Volumn 7, Issue 4, 2013, Pages

  Zhang, Boyang ^a,b   Peticone, Carlotta ^a   Murthy, Shashi K ^c,d   Radisic, Milica ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Northeastern University   (United States)

^d NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; BLOOD VESSELS; DRUG PRODUCTS; ENDOTHELIAL CELLS; MICROFLUIDICS; NITRIC OXIDE; SHEAR FLOW; SHEAR STRESS;

BRANCHING STRUCTURES; COMPLEX ARCHITECTURES; GEOMETRICAL CONFIGURATIONS; INTERACTIVE EFFECT; MICROFLUIDIC PLATFORMS; PHARMACOLOGICAL AGENTS; RECTANGULAR CHANNEL; TUMOR NECROSIS FACTOR ALPHA;

DRUG DOSAGE;

EID: 84883418408     PISSN: 19321058     EISSN: None     Source Type: Journal    
DOI: 10.1063/1.4818837     Document Type: Article

References (31)

1. Domansky K. Inman W. Serdy J. Dash A. Lim M.H. M. Perfused multiwell plate for 3D liver tissue engineering. Lab Chip 2010, 10:51-58. 10.1039/b913221j.
2. Huh D. Matthews B.D. Mammoto A. Montoya-Zavala M. Hsin H.Y. Reconstituting organ-level lung functions on chip. Science 2010, 328:1662-1668. 10.1126/science.1188302.
3. Grosberg A. Alford P.W. McCain M.L. Parker K.K. Ensembles of engineered cardiac tissues for physiological and pharmacological study: Heart on a chip. Lab Chip 2011, 11:4165-4173. 10.1039/c1lc20557a.
4. Frangos J.A. McIntire L.V. Eskin S.G. Shear stress induced stimulation of mammalian cell metabolism. Biotechnol. Bioeng. 1988, 32:1053-1060. 10.1002/bit.260320812.
5. Srigunapalan S. Lam C. Wheeler A.R. Simmons C.A. A microfluidic membrane device to mimic critical components of the vascular microenvironment. Biomicrofluidics 2011, 5:13409. 10.1063/1.3530598.
6. Zheng Y. Chen J. Craven M. Choi N.W. Totorica S. In vitro microvessels for the study of angiogenesis and thrombosis. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:9342-9347. 10.1073/pnas.1201240109.
7. Rotenberg M.Y. Ruvinov E. Armoza A. Cohen S. A multi-shear perfusion bioreactor for investigating shear stress effects in endothelial cell constructs. Lab Chip 2012, 12:2696-2703. 10.1039/C2LC40144D.
8. Tsai M. Kita A. Leach J. Rounsevell R. Huang J.N. In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. J. Clin. Invest. 2012, 122:408-418. 10.1172/JCI58753.
9. Chau L.T. Rolfe B.E. Cooper-White J.J. A microdevice for the creation of patent, three-dimensional endothelial cell-based microcirculatory networks. Biomicrofluidics 2011, 5:034115. 10.1063/1.3609264.
10. Truslow J.G. Tien J. Perfusion systems that minimize vascular volume fraction in engineered tissues. Biomicrofluidics 2011, 5:22201. 10.1063/1.3576926.
11. Jeon N.L. In vitro formation and characterization of a perfusable three-dimensional tubular capillary network in microfluidic devices. Lab Chip 2012, 12:2815-2822. 10.1039/C2LC40131B.
12. Darby S.G. Moore M.R. Friedlander T.A. Schaffer D.K. Reiserer R.S. A metering rotary nanopump for microfluidic systems. Lab Chip 2010, 10:3218-3226. 10.1039/c0lc00087f.
13. Zhang B. Green J.V. Murthy S.K. Radisic M. Label-free enrichment of functional cardiomyocytes using microfluidic deterministic lateral flow displacement. PLoS ONE 2012, 7:e37619. 10.1371/journal.pone.0037619.
14. Eddington D.T. Chips & Tips: In-line microfluidic bubble trap. Lab Chip "," (published online), available at.
15. Fiddes L.K. Raz N. Srigunapalan S. Tumarkan E. Simmons C.A. A circular cross-section PDMS microfluidics system for replication of cardiovascular flow conditions. Biomaterials 2010, 31:3459-3464. 10.1016/j.biomaterials.2010.01.082.
16. Huynh J. Nishimura N. Rana K. Peloquin J.M. Califano J.P. Age-related intimal stiffening enhances endothelial permeability and leukocyte transmigration. Sci. Trans. Med. 2011, 3:112ra122. 10.1126/scitranslmed.3002761.
17. Aird W.C. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ. Res. 2007, 100:158-173. 10.1161/01.RES.0000255691.76142.4a.
18. Kellogg D.L. Zhao J.L. Coey U. Green J.V. Acetylcholine-induced vasodilation is mediated by nitric oxide and prostaglandins in human skin. J. Appl. Physiol. 2005, 98:629-632. 10.1152/japplphysiol.00728.2004.
19. Chataigneau T. Félétou M. Huang P.L. Fishman M.C. Duhault J. Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice. Br. J. Pharmacol. 1999, 126:219-226. 10.1038/sj.bjp.0702300.
20. Gunther A. Yasotharan S. Vagaon A. Lochovsky C. Pinto S. A microfluidic platform for probing small artery structure and function. Lab Chip 2010, 10:2341-2349. 10.1039/c004675b.
21. Atar S. Ye Y. Lin Y. Freeberg S.Y. Nishi S.P. Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H1960-1968. 10.1152/ajpheart.01137.2005.
22. Mahmoud M.F. El-Nagar M. El-Bassossy H.M. Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats. Arch. Pharmacal Res. 2012, 35:155-162. 10.1007/s12272-012-0117-8.
23. Dishy V. Sofowora G. Harris P.A. Kandcer M. Zhan F. The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men. Clin. Pharmacol. Ther. 2001, 70:270-279. 10.1067/mcp.2001.117995.
24. Mammi C. Pastore D. Lombardo M.F. Ferrelli F. Caprio M. Sildenafil reduces insulin-resistance in human endothelial cells. PLoS ONE 2011, 6:e14542. 10.1371/journal.pone.0014542.
25. Buxbaum J.D. Oishi M. Chen H.I. Pinkas-Kramarski R. Jaffe E.A. Cholinergic agonists and interleukin regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:10075-10078. 10.1073/pnas.89.21.10075.
26. Jackson G. Benjamin N. Jackson N. Allen M.J. Effects of sildenafil citrate on human hemodynamics. Am. J. Cardiol. 1999, 83:13-20. 10.1016/S0002-9149(99)00043-0.
27. Das A. Xi L. Kukreja R.C. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J. Biol. Chem. 2005, 280:12944-12955. 10.1074/jbc.M404706200.
28. Salom J.B. Burguete M.C. Pérez-Asensio F.J. Castelló-Ruiz M. Torregrosa G. Relaxant effect of sildenafil in the rabbit basilar artery. Vasc. Pharmacol. 2006, 44:10-16. 10.1016/j.vph.2005.07.010.
29. Francis S.H. Busch J.L. Corbin J.D. Sibley D. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol. Rev. 2010, 62:525-563. 10.1124/pr.110.002907.
30. Lee K.-W. Stolz D.B. Wang Y. Substantial expression of mature elastin in arterial constructs. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:2705-2710. 10.1073/pnas.1017834108.
31. Li L.-M. Wang X.-Y. Hu L.-S. Chen R.-S. Huang Y. Vascular lumen simulation and highly-sensitive nitric oxide detection using three-dimensional gelatin chip coupled to TiC/C nanowire arrays microelectrode. Lab Chip 2012, 12:4249-4256. 10.1039/c2lc40148g.